Kim A. Reiss Binder, MD

Kim A. Reiss Binder, MD, is the assistant program director of the Hematology/Oncology Fellowship Program and an associate professor of medicine (hematology-oncology) at the Hospital of the University of Pennsylvania

Articles by Kim A. Reiss Binder, MD

Pancreatic cancer | Image Credit: © Image by Ashling Wahner & MJH Life Sciences Using AI

Dr Reiss Binder on the FDA Approval of Daraxonrasib for Metastatic PDAC

ByKim A. Reiss Binder, MD

August 26th 2026

Kim A. Reiss Binder, MD, notes the significance of the approval of daraxonrasib for metastatic PDAC and how it positions a new era for RAS-targeted drugs.

Dr. Reiss Binder on Initial Results of a Phase 1 Study of CT-0508 in HER2+ Solid Tumors

ByKim A. Reiss Binder, MD

November 23rd 2021

Kim A. Reiss Binder, MD, discusses the initial results of a phase 1 trial, which is evaluating CT-0508 in patients with HER2-overexpressing solid tumors.

Dr. Binder on Data Regarding Rucaparib Maintenance in Pancreatic Cancer

ByKim A. Reiss Binder, MD

April 24th 2019

Kim A. Reiss Binder, MD, assistant professor of medicine in the Division of Hematology Oncology at the University of Pennsylvania, discusses data on maintenance therapy with rucaparib (Rubraca) in patients with pancreatic cancer.